What sector does ADC Therapeutics SA (ADCT) operate in?
ADC Therapeutics SA belongs to the Information Technology sector and operates in the Biotechnology industry.
What is ADC Therapeutics SA (ADCT) current stock price?
As of the latest data, ADC Therapeutics SA stock price is $3.73, with a previous close of $3.70. ADC Therapeutics SA gained $0.03 in the last trading session, representing a 0.68% increase.
What is ADC Therapeutics SA (ADCT) current market capitalization?
ADC Therapeutics SA market cap is approximately 419.06 million.
What is ADC Therapeutics SA (ADCT) Earnings Per Share (EPS)?
The trailing EPS is -$1.41, and the forward EPS is -$1.30.
What is ADC Therapeutics SA (ADCT) EBITDA?
ADC Therapeutics SA EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -41.55 million.
Does ADC Therapeutics SA (ADCT) pay dividends?
No. ADC Therapeutics SA does not pay a dividend.
How did ADC Therapeutics SA (ADCT) perform in its most recent earnings report?
In the last report (September 30, 2025), ADC Therapeutics SA posted an EPS surprise of 35.9% and a revenue surprise of 5.48%.
When is ADC Therapeutics SA (ADCT) next earnings report?
ADC Therapeutics SA is expected to release its next earnings report on December 31, 2025.
What is ADC Therapeutics SA (ADCT) beta (volatility) score?
ADC Therapeutics SA has a beta of 1.893, suggesting it is more volatile than the market.